Delivery Order SPE2DB20D1051-SPE2DB25FD9MV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,439.29 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 mL pen injectors with a completion date of July 29, 2025. This firm fixed-price delivery order, issued on July 28, 2025, represents a competitively awarded contract with no set-aside designation. The product will be supplied from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $4,353.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Mounjaro 10 mg/0.5 mL pen injectors. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 12, 2025, and performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a single transaction under a larger indefinite delivery vehicle that enables DLA to...
- The Defense Logistics Agency awarded a delivery order valued at $13,780.15 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injectors on July 21, 2025, with completion targeted for July 22, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Mounjaro 10 mg/0.5 mL pen injectors valued at $2,934.71. This is a firm fixed-price delivery order with an ultimate completion date of July 18, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors with a ceiling value of $1,578.87. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and carries no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,176.72 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The contract represents a single transaction under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a $34,843.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Mounjaro 15 mg/0.5 ml pen injectors. The contract, which is a child order under a larger indefinite delivery vehicle, has an ultimate completion date of September 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 mL pen injectors valued at $1,632.54. This competitively awarded, non-set-aside contract was executed on August 26, 2025, with an ultimate completion date of August 27, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $4,241.13 delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injectors (0.5 ml units). This is a firm fixed-price delivery order with no set-aside designation, completed through open competition. The order is scheduled for ultimate completion on April 25, 2025, with performance based in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,405.78 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pen injectors on June 18, 2025, with a completion date of June 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB25FD9MVDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 2.5 mg/0.5 mL pen injectors valued at $4,081.35 under a firm fixed-price contract. The order was placed on September 16, 2025, with an ultimate completion date of September 17, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a single transaction under AmerisourceBergen's existing federal pharmaceutical supply agreement. This contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The Mounjaro delivery represents part of the company's broader pharmaceutical portfolio supporting the Defense Health Agency and other government healthcare systems through flexible and competitively awarded contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 9/16/25 |